Videos

What to Expect With a High Risk of Head and Neck Cancer Recurrence

August 29th 2024, 9:00pm

Video

Patients who have a higher risk of head and neck cancer recurrence can expect more — and sooner — monitoring of their disease.

Advancing CML Management Towards an Ideal Patient Journey

August 28th 2024, 12:00pm

Video

The panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.

‘No Such Thing as a Good Cancer’: Explaining the Big CLL Misconception

August 23rd 2024, 7:00pm

Video

One expert explained why chronic lymphocytic leukemia is erroneously considered a ‘good cancer.’

Resources Available to Patients With CLL

August 23rd 2024, 7:00pm

Video

From social work to cardio-oncology, there is a wide array of resources potentially available to patients, as one expert explained.

What Patients with CLL Need to Know About Clinical Trials

August 23rd 2024, 7:00pm

Video

One expert explains why most of the time clinical trial enrollment is ‘the correct answer’ for patients.

With CLL ‘Cancer Gets Smart, And We Have to Evolve with the Cancer’

August 23rd 2024, 7:00pm

Video

There have been major treatment advancements for CLL in the last decade, with future generations of drugs on the horizon.

Unmet Needs and Challenges in Metastatic Uveal Melanoma

August 23rd 2024, 4:10pm

Video

Experts discuss unmet needs and challenges faced by patients with uveal melanoma. This program was made possible with support from Immunocore.

Safety and Efficacy of Tebentafusp

August 23rd 2024, 4:05pm

Video

Nathan L. Scott, M.D., discusses the safety and efficacy of tebentafusp. This program was made possible with support from Immunocore.

Choosing the Appropriate Treatment for Metastatic Uveal Melanoma

August 23rd 2024, 3:59pm

Video

Nathan L. Scott, M.D., provides a brief overview of the current guidelines for treatment of metastatic uveal melanoma, as well as what considerations go into choosing the appropriate treatment for it. This program was made possible with support from Immunocore.

Uveal Melanoma Prognosis and Risk Stratification

August 23rd 2024, 3:52pm

Video

Nathan L. Scott, M.D., discusses the risk of recurrence within diagnosed uveal melanoma patients. Uveal Melanoma Prognosis and Risk Stratification